ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Sep 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
Fusion Science and Technology
August 2025
Latest News
From operator to entrepreneur: David Garcia applies outage management lessons
David Garcia
If ComEd’s Zion plant in northern Illinois hadn’t closed in 1998, David Garcia might still be there, where he got his start in nuclear power as an operator at age 24.
But in his ninth year working there, Zion closed, and Garcia moved on to a series of new roles—including at Wisconsin’s Point Beach plant, the corporate offices of Minnesota’s Xcel Energy, and on the supplier side at PaR Nuclear—into an on-the-job education that he augmented with degrees in business and divinity that he sought later in life.
Garcia started his own company—Waymaker Resource Group—in 2014. Recently, Waymaker has been supporting Holtec’s restart project at the Palisades plant with staffing and analysis. Palisades sits almost exactly due east of the fully decommissioned Zion site on the other side of Lake Michigan and is poised to operate again after what amounts to an extended outage of more than three years. Holtec also plans to build more reactors at the same site.
For Garcia, the takeaway is clear: “This industry is not going away. Nuclear power and the adjacent industries that support nuclear power—and clean energy, period—are going to be needed for decades upon decades.”
In July, Garcia talked with Nuclear News staff writer Susan Gallier about his career and what he has learned about running successful outages and other projects.
Z. Z. Johal, J. W. Crippen, A. C. Forsman, E. H. Lundgren, K. A. Moreno, A. Nikroo
Fusion Science and Technology | Volume 55 | Number 3 | April 2009 | Pages 331-336
Technical Paper | Eighteenth Target Fabrication Specialists' Meeting | doi.org/10.13182/FST08-3503
Articles are hosted by Taylor and Francis Online.
The National Ignition Facility (NIF) tuning and ignition capsules will be gas filled through a laser precision drilled hole with a fill tube attached. To field these targets, several physics and assembly requirements must be met. These requirements drive the morphology of the final capsule and fill tube assembly (CFTA). Unexpectedly, they have also driven the need for a fill tube-transition tube subassembly, which is significant in the extra time required for fabrication. We have implemented engineering solutions that allow successful fabrication, testing, and transportation of CFTAs. During fabrication the fill tube is vertically inserted into both the transition tube and capsule, it is adhered with a low-viscosity adhesive, and there is a gap between mating surfaces. Nitrogen backpressure is flowed through the transition tube to prevent wicking of adhesive into the fill tube and to prevent partial restriction of flow or plugging. A nitrogen purge has also been implemented to displace atmospheric oxygen, which would otherwise absorb into the adhesive surface, truncate the polymerization process, and lead to a partially cured joint. Prior to transportation, the CFTA must complete a series of testing that simulates final assembly and NIF conditions: (a) helium leak test at room temperature, (b) helium leak test at liquid nitrogen temperature, (c) pressure test, and (d) X-ray fluorescence testing. The CFTA is transported in a custom device that provides vital support for the fill tube-to-capsule interface.